Abstract
A magnetic nanosystem that simultaneously implements the cyclodextrin–drug complexation power, bioadhesive property of gum arabic (GA) and inherent magnetic properties of Fe3O4 nanoparticles, has recently been reported. In this study, a magnetic nanocarrier was fabricated by conjugating 2-hydroxypropyl-cyclodextrin (HCD) onto the gum arabic modified magnetic nanoparticles (GAMNP). The analyses of transmission electron microscopy (TEM) and dynamic light scattering (DLS) revealed that the product had a mean diameter of 14.8 nm and a mean hydrodynamic diameter of 29.3 nm. This nanocarrier showed good loading efficiency for ketoprofen. In addition, the in vitro release profile of ketoprofen from HCD-GAMNP was characterized by an initial fast release followed by a delayed release phase. In view of the better biocompatibility and the combined properties like specific targeting, complexation ability with hydrophobic drugs makes the nanosystem an exciting prospect for drug delivery.
Similar content being viewed by others
References
Banerjee SS, Chen DH (2007a) Magnetic nanoparticles grafted with cyclodextrin for hydrophobic drug delivery. Chem Mater 19:6345–6349. doi:10.1021/cm702278u
Banerjee SS, Chen DH (2007b) Fast removal of copper ions by gum arabic modified magnetic nano-adsorbent. J Hazard Mater 147:792–799. doi:10.1016/j.jhazmat.2007.01.079
Bender M, Komiyama M (1978) Cyclodextrin chemistry. Springer, Berlin
Brewster ME, Loftsson T (2007) Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645–666. doi:10.1016/j.addr.2007.05.012
Brewster ME, Mackie C et al (2007) The use of solubilizing excipients and approaches to generate toxicology vehicles for contemporary drug pipelines. In: Augustijns P, Brewster ME (eds) Solvent systems and their selection in pharmaceutics and biopharmaceutics. American Association of Pharmaceutical Scientists and Springer, New York, pp 221–266
Catena GC, Bright FV (1989) Thermodynamic study on the effects of beta-cyclodextrin inclusion with anilinonaphthalenesulfonates. Anal Chem 61:905–909. doi:10.1021/ac00183a024
Cinteza LO, Ohulchanskyy TY et al (2006) Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 3:415–423. doi:10.1021/mp060015p
Gould S, Scott RC (2005) 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem Toxicol 43:1451–1459. doi:10.1016/j.fct.2005.03.007
Jeong U, Teng X et al (2007) Superparamagnetic colloids: controlled synthesis and niche applications. Adv Mater 19:33–60. doi:10.1002/adma.200600674
Junquera E, Aicart E (1997) Potentiometric study of the encapsulation of ketoprophen by hydroxypropyl-β- cyclodextrin. Temperature, solvent, and salt effects. J Phys Chem B 101:7163–7171. doi:10.1021/jp963977s
Jurgons R, Seliger C et al (2006) Drug loaded magnetic nanoparticles for cancer therapy. J Phys Condens Matter 18:S2893–S2902. doi:10.1088/0953-8984/18/38/S24
Kohler H, Sun C et al (2005) Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21:8858–8864. doi:10.1021/la0503451
Lee H, Yu MK, Park S, Moon S et al (2007) Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 129:12739–12745. doi:10.1021/ja072210i
Liao MH, Chen DH (2002) Preparation and characterization of a novel magnetic nano-adsorbent. J Mater Chem 12:3654–3659. doi:10.1039/b207158d
Loftsson T, Masson M (2001) Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm 225:15–30. doi:10.1016/S0378-5173(01)00761-X
Nasongkla N, Bey E et al (2006) Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 6:2427–2430. doi:10.1021/nl061412u
Nelles G, Weisser M et al (1996) J Am Chem Soc 118:5039–5046. doi:10.1021/ja9539812
Rao VM, Nerurkar M (2006) Co-solubilization of poorly soluble drugs by micellization and complexation. Int J Pharm 319:98–106. doi:10.1016/j.ijpharm.2006.03.042
Rozou S, Michaleas S et al (2005) Study of structural features and thermodynamic parameters, determining the chromatographic behaviour of drug–cyclodextrin complexes. J Chromatogr A 1087:86–94. doi:10.1016/j.chroma.2005.02.039
Saenger W (1984) Inclusion compounds. Academic Press, London
Sashiwa H, Saimoto H et al (1990) Lysozyme susceptibility of partially deacetylated chitin. Int J Biol Macromol 12:295–296. doi:10.1016/0141-8130(90)90016-4
Takada K (2006) Oral formulation for gastrointestinal drug delivery. US Patent 7097851 B1
Acknowledgment
This work was supported by the Landmark Project of National Cheng Kung University, Taiwan. We are also grateful to the National Science Council (Contract No. NSC 95-2221-E006-406-MY2) of the Republic of China for the support of this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Banerjee, S.S., Chen, DH. Cyclodextrin-conjugated nanocarrier for magnetically guided delivery of hydrophobic drugs. J Nanopart Res 11, 2071–2078 (2009). https://doi.org/10.1007/s11051-008-9572-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-008-9572-z